menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

How Novo Nordisk failed to protect its GLP-1 patent

5 1
02.09.2025
Traditional intellectual property tools have proved insufficient against pharmacy compounders producing weight-loss drugs

© Financial Times